Copyright Reports & Markets. All rights reserved.

Global Acute Respiratory Distress Syndrome Therapeutics Market Research Report 2019

Request for Sample of this report
Buy now

Table of Contents

    Executive Summary

      1 Acute Respiratory Distress Syndrome Therapeutics Market Overview

      • 1.1 Product Overview and Scope of Acute Respiratory Distress Syndrome Therapeutics
      • 1.2 Acute Respiratory Distress Syndrome Therapeutics Segment by Type
        • 1.2.1 Global Acute Respiratory Distress Syndrome Therapeutics Production Growth Rate Comparison by Type (2014-2025)
        • 1.2.2 Methylprednisolone
        • 1.2.3 Hydrocortisone
        • 1.2.4 Calf Pulmonary Surfactant for Injection
        • 1.2.5 Others
      • 1.3 Acute Respiratory Distress Syndrome Therapeutics Segment by Application
        • 1.3.1 Acute Respiratory Distress Syndrome Therapeutics Consumption Comparison by Application (2014-2025)
        • 1.3.2 In-Patient
        • 1.3.3 Out-Patient
      • 1.3 Global Acute Respiratory Distress Syndrome Therapeutics Market by Region
        • 1.3.1 Global Acute Respiratory Distress Syndrome Therapeutics Market Size Region
        • 1.3.2 North America Status and Prospect (2014-2025)
        • 1.3.3 Europe Status and Prospect (2014-2025)
        • 1.3.4 China Status and Prospect (2014-2025)
        • 1.3.5 Japan Status and Prospect (2014-2025)
        • 1.3.6 Southeast Asia Status and Prospect (2014-2025)
        • 1.3.7 India Status and Prospect (2014-2025)
      • 1.4 Global Acute Respiratory Distress Syndrome Therapeutics Market Size
        • 1.4.1 Global Acute Respiratory Distress Syndrome Therapeutics Revenue (2014-2025)
        • 1.4.2 Global Acute Respiratory Distress Syndrome Therapeutics Production (2014-2025)

      2 Global Acute Respiratory Distress Syndrome Therapeutics Market Competition by Manufacturers

      • 2.1 Global Acute Respiratory Distress Syndrome Therapeutics Production Market Share by Manufacturers (2014-2019)
      • 2.2 Global Acute Respiratory Distress Syndrome Therapeutics Revenue Share by Manufacturers (2014-2019)
      • 2.3 Global Acute Respiratory Distress Syndrome Therapeutics Average Price by Manufacturers (2014-2019)
      • 2.4 Manufacturers Acute Respiratory Distress Syndrome Therapeutics Production Sites, Area Served, Product Types
      • 2.5 Acute Respiratory Distress Syndrome Therapeutics Market Competitive Situation and Trends
        • 2.5.1 Acute Respiratory Distress Syndrome Therapeutics Market Concentration Rate
        • 2.5.2 Acute Respiratory Distress Syndrome Therapeutics Market Share of Top 3 and Top 5 Manufacturers
        • 2.5.3 Mergers & Acquisitions, Expansion

      3 Global Acute Respiratory Distress Syndrome Therapeutics Production Market Share by Regions

      • 3.1 Global Acute Respiratory Distress Syndrome Therapeutics Production Market Share by Regions
      • 3.2 Global Acute Respiratory Distress Syndrome Therapeutics Revenue Market Share by Regions (2014-2019)
      • 3.3 Global Acute Respiratory Distress Syndrome Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.4 North America Acute Respiratory Distress Syndrome Therapeutics Production
        • 3.4.1 North America Acute Respiratory Distress Syndrome Therapeutics Production Growth Rate (2014-2019)
        • 3.4.2 North America Acute Respiratory Distress Syndrome Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.5 Europe Acute Respiratory Distress Syndrome Therapeutics Production
        • 3.5.1 Europe Acute Respiratory Distress Syndrome Therapeutics Production Growth Rate (2014-2019)
        • 3.5.2 Europe Acute Respiratory Distress Syndrome Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.6 China Acute Respiratory Distress Syndrome Therapeutics Production (2014-2019)
        • 3.6.1 China Acute Respiratory Distress Syndrome Therapeutics Production Growth Rate (2014-2019)
        • 3.6.2 China Acute Respiratory Distress Syndrome Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.7 Japan Acute Respiratory Distress Syndrome Therapeutics Production (2014-2019)
        • 3.7.1 Japan Acute Respiratory Distress Syndrome Therapeutics Production Growth Rate (2014-2019)
        • 3.7.2 Japan Acute Respiratory Distress Syndrome Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)

      4 Global Acute Respiratory Distress Syndrome Therapeutics Consumption by Regions

      • 4.1 Global Acute Respiratory Distress Syndrome Therapeutics Consumption by Regions
      • 4.2 North America Acute Respiratory Distress Syndrome Therapeutics Consumption (2014-2019)
      • 4.3 Europe Acute Respiratory Distress Syndrome Therapeutics Consumption (2014-2019)
      • 4.4 China Acute Respiratory Distress Syndrome Therapeutics Consumption (2014-2019)
      • 4.5 Japan Acute Respiratory Distress Syndrome Therapeutics Consumption (2014-2019)

      5 Global Acute Respiratory Distress Syndrome Therapeutics Production, Revenue, Price Trend by Type

      • 5.1 Global Acute Respiratory Distress Syndrome Therapeutics Production Market Share by Type (2014-2019)
      • 5.2 Global Acute Respiratory Distress Syndrome Therapeutics Revenue Market Share by Type (2014-2019)
      • 5.3 Global Acute Respiratory Distress Syndrome Therapeutics Price by Type (2014-2019)
      • 5.4 Global Acute Respiratory Distress Syndrome Therapeutics Production Growth by Type (2014-2019)

      6 Global Acute Respiratory Distress Syndrome Therapeutics Market Analysis by Applications

      • 6.1 Global Acute Respiratory Distress Syndrome Therapeutics Consumption Market Share by Application (2014-2019)
      • 6.2 Global Acute Respiratory Distress Syndrome Therapeutics Consumption Growth Rate by Application (2014-2019)

      7 Company Profiles and Key Figures in Acute Respiratory Distress Syndrome Therapeutics Business

      • 7.1 Therabron Therapeutics, Inc.
        • 7.1.1 Therabron Therapeutics, Inc. Acute Respiratory Distress Syndrome Therapeutics Production Sites and Area Served
        • 7.1.2 Acute Respiratory Distress Syndrome Therapeutics Product Introduction, Application and Specification
        • 7.1.3 Therabron Therapeutics, Inc. Acute Respiratory Distress Syndrome Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.1.4 Main Business and Markets Served
      • 7.2 Serendex Pharmaceuticals A/S
        • 7.2.1 Serendex Pharmaceuticals A/S Acute Respiratory Distress Syndrome Therapeutics Production Sites and Area Served
        • 7.2.2 Acute Respiratory Distress Syndrome Therapeutics Product Introduction, Application and Specification
        • 7.2.3 Serendex Pharmaceuticals A/S Acute Respiratory Distress Syndrome Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.2.4 Main Business and Markets Served
      • 7.3 Silence Therapeutics Plc
        • 7.3.1 Silence Therapeutics Plc Acute Respiratory Distress Syndrome Therapeutics Production Sites and Area Served
        • 7.3.2 Acute Respiratory Distress Syndrome Therapeutics Product Introduction, Application and Specification
        • 7.3.3 Silence Therapeutics Plc Acute Respiratory Distress Syndrome Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.3.4 Main Business and Markets Served
      • 7.4 Histocell S.L.
        • 7.4.1 Histocell S.L. Acute Respiratory Distress Syndrome Therapeutics Production Sites and Area Served
        • 7.4.2 Acute Respiratory Distress Syndrome Therapeutics Product Introduction, Application and Specification
        • 7.4.3 Histocell S.L. Acute Respiratory Distress Syndrome Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.4.4 Main Business and Markets Served
      • 7.5 Altor BioScience Corporation
        • 7.5.1 Altor BioScience Corporation Acute Respiratory Distress Syndrome Therapeutics Production Sites and Area Served
        • 7.5.2 Acute Respiratory Distress Syndrome Therapeutics Product Introduction, Application and Specification
        • 7.5.3 Altor BioScience Corporation Acute Respiratory Distress Syndrome Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.5.4 Main Business and Markets Served
      • 7.6 Athersys, Inc.
        • 7.6.1 Athersys, Inc. Acute Respiratory Distress Syndrome Therapeutics Production Sites and Area Served
        • 7.6.2 Acute Respiratory Distress Syndrome Therapeutics Product Introduction, Application and Specification
        • 7.6.3 Athersys, Inc. Acute Respiratory Distress Syndrome Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.6.4 Main Business and Markets Served
      • 7.7 Faron Pharmaceuticals Oy
        • 7.7.1 Faron Pharmaceuticals Oy Acute Respiratory Distress Syndrome Therapeutics Production Sites and Area Served
        • 7.7.2 Acute Respiratory Distress Syndrome Therapeutics Product Introduction, Application and Specification
        • 7.7.3 Faron Pharmaceuticals Oy Acute Respiratory Distress Syndrome Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.7.4 Main Business and Markets Served
      • 7.8 FirstString Research, Inc.
        • 7.8.1 FirstString Research, Inc. Acute Respiratory Distress Syndrome Therapeutics Production Sites and Area Served
        • 7.8.2 Acute Respiratory Distress Syndrome Therapeutics Product Introduction, Application and Specification
        • 7.8.3 FirstString Research, Inc. Acute Respiratory Distress Syndrome Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.8.4 Main Business and Markets Served
      • 7.9 GlaxoSmithKline Plc
        • 7.9.1 GlaxoSmithKline Plc Acute Respiratory Distress Syndrome Therapeutics Production Sites and Area Served
        • 7.9.2 Acute Respiratory Distress Syndrome Therapeutics Product Introduction, Application and Specification
        • 7.9.3 GlaxoSmithKline Plc Acute Respiratory Distress Syndrome Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.9.4 Main Business and Markets Served
      • 7.10 Phylogica Limited
        • 7.10.1 Phylogica Limited Acute Respiratory Distress Syndrome Therapeutics Production Sites and Area Served
        • 7.10.2 Acute Respiratory Distress Syndrome Therapeutics Product Introduction, Application and Specification
        • 7.10.3 Phylogica Limited Acute Respiratory Distress Syndrome Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.10.4 Main Business and Markets Served

      8 Acute Respiratory Distress Syndrome Therapeutics Manufacturing Cost Analysis

      • 8.1 Acute Respiratory Distress Syndrome Therapeutics Key Raw Materials Analysis
        • 8.1.1 Key Raw Materials
        • 8.1.2 Price Trend of Key Raw Materials
        • 8.1.3 Key Suppliers of Raw Materials
      • 8.2 Proportion of Manufacturing Cost Structure
      • 8.3 Manufacturing Process Analysis of Acute Respiratory Distress Syndrome Therapeutics
      • 8.4 Acute Respiratory Distress Syndrome Therapeutics Industrial Chain Analysis

      9 Marketing Channel, Distributors and Customers

      • 9.1 Marketing Channel
        • 9.1.1 Direct Marketing
        • 9.1.2 Indirect Marketing
      • 9.2 Acute Respiratory Distress Syndrome Therapeutics Distributors List
      • 9.3 Acute Respiratory Distress Syndrome Therapeutics Customers

      10 Market Dynamics

      • 10.1 Market Trends
      • 10.2 Opportunities
      • 10.3 Market Drivers
      • 10.4 Challenges
      • 10.5 Influence Factors

      11 Global Acute Respiratory Distress Syndrome Therapeutics Market Forecast

      • 11.1 Global Acute Respiratory Distress Syndrome Therapeutics Production, Revenue Forecast
        • 11.1.1 Global Acute Respiratory Distress Syndrome Therapeutics Production Growth Rate Forecast (2019-2025)
        • 11.1.2 Global Acute Respiratory Distress Syndrome Therapeutics Revenue and Growth Rate Forecast (2019-2025)
        • 11.1.3 Global Acute Respiratory Distress Syndrome Therapeutics Price and Trend Forecast (2019-2025)
      • 11.2 Global Acute Respiratory Distress Syndrome Therapeutics Production Forecast by Regions (2019-2025)
        • 11.2.1 North America Acute Respiratory Distress Syndrome Therapeutics Production, Revenue Forecast (2019-2025)
        • 11.2.2 Europe Acute Respiratory Distress Syndrome Therapeutics Production, Revenue Forecast (2019-2025)
        • 11.2.3 China Acute Respiratory Distress Syndrome Therapeutics Production, Revenue Forecast (2019-2025)
        • 11.2.4 Japan Acute Respiratory Distress Syndrome Therapeutics Production, Revenue Forecast (2019-2025)
      • 11.3 Global Acute Respiratory Distress Syndrome Therapeutics Consumption Forecast by Regions (2019-2025)
        • 11.3.1 North America Acute Respiratory Distress Syndrome Therapeutics Consumption Forecast (2019-2025)
        • 11.3.2 Europe Acute Respiratory Distress Syndrome Therapeutics Consumption Forecast (2019-2025)
        • 11.3.3 China Acute Respiratory Distress Syndrome Therapeutics Consumption Forecast (2019-2025)
        • 11.3.4 Japan Acute Respiratory Distress Syndrome Therapeutics Consumption Forecast (2019-2025)
      • 11.4 Global Acute Respiratory Distress Syndrome Therapeutics Production, Revenue and Price Forecast by Type (2019-2025)
      • 11.5 Global Acute Respiratory Distress Syndrome Therapeutics Consumption Forecast by Application (2019-2025)

      12 Research Findings and Conclusion

        13 Methodology and Data Source

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        The global Acute Respiratory Distress Syndrome Therapeutics market is valued at million US$ in 2018 is expected to reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
        This report focuses on Acute Respiratory Distress Syndrome Therapeutics volume and value at global level, regional level and company level. From a global perspective, this report represents overall Acute Respiratory Distress Syndrome Therapeutics market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
        At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

        The following manufacturers are covered:
        Therabron Therapeutics, Inc.
        Serendex Pharmaceuticals A/S
        Silence Therapeutics Plc
        Histocell S.L.
        Altor BioScience Corporation
        Athersys, Inc.
        Faron Pharmaceuticals Oy
        FirstString Research, Inc.
        GlaxoSmithKline Plc
        Phylogica Limited

        Segment by Regions
        North America
        Europe
        China
        Japan

        Segment by Type
        Methylprednisolone
        Hydrocortisone
        Calf Pulmonary Surfactant for Injection
        Others

        Segment by Application
        In-Patient
        Out-Patient

        Buy now